Cargando…
Chondroprotection and Molecular Mechanism of Action of Phytonutraceuticals on Osteoarthritis
Osteoarthritis (OA) is a degenerative joint disease and an important cause of incapacitation. There is a lack of drugs and effective treatments that stop or slow the OA progression. Modern pharmacological treatments, such as analgesics, have analgesic effects but do not affect the course of OA. Long...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074261/ https://www.ncbi.nlm.nih.gov/pubmed/33924083 http://dx.doi.org/10.3390/molecules26082391 |
_version_ | 1783684315192754176 |
---|---|
author | Sukhikh, Stanislav Noskova, Svetlana Ivanova, Svetlana Ulrikh, Elena Izgaryshev, Alexsander Babich, Olga |
author_facet | Sukhikh, Stanislav Noskova, Svetlana Ivanova, Svetlana Ulrikh, Elena Izgaryshev, Alexsander Babich, Olga |
author_sort | Sukhikh, Stanislav |
collection | PubMed |
description | Osteoarthritis (OA) is a degenerative joint disease and an important cause of incapacitation. There is a lack of drugs and effective treatments that stop or slow the OA progression. Modern pharmacological treatments, such as analgesics, have analgesic effects but do not affect the course of OA. Long-term use of these drugs can lead to serious side effects. Given the OA nature, it is likely that lifelong treatment will be required to stop or slow its progression. Therefore, there is an urgent need for disease-modifying OA treatments that are also safe for clinical use over long periods. Phytonutraceuticals are herbal products that provide a therapeutic effect, including disease prevention, which not only have favorable safety characteristics but may have an alleviating effect on the OA and its symptoms. An estimated 47% of OA patients use alternative drugs, including phytonutraceuticals. The review studies the efficacy and action mechanism of widely used phytonutraceuticals, analyzes the available experimental and clinical data on the effect of some phytonutraceuticals (phytoflavonoids, polyphenols, and bioflavonoids) on OA, and examines the known molecular effect and the possibility of their use for chondroprotection. |
format | Online Article Text |
id | pubmed-8074261 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80742612021-04-27 Chondroprotection and Molecular Mechanism of Action of Phytonutraceuticals on Osteoarthritis Sukhikh, Stanislav Noskova, Svetlana Ivanova, Svetlana Ulrikh, Elena Izgaryshev, Alexsander Babich, Olga Molecules Review Osteoarthritis (OA) is a degenerative joint disease and an important cause of incapacitation. There is a lack of drugs and effective treatments that stop or slow the OA progression. Modern pharmacological treatments, such as analgesics, have analgesic effects but do not affect the course of OA. Long-term use of these drugs can lead to serious side effects. Given the OA nature, it is likely that lifelong treatment will be required to stop or slow its progression. Therefore, there is an urgent need for disease-modifying OA treatments that are also safe for clinical use over long periods. Phytonutraceuticals are herbal products that provide a therapeutic effect, including disease prevention, which not only have favorable safety characteristics but may have an alleviating effect on the OA and its symptoms. An estimated 47% of OA patients use alternative drugs, including phytonutraceuticals. The review studies the efficacy and action mechanism of widely used phytonutraceuticals, analyzes the available experimental and clinical data on the effect of some phytonutraceuticals (phytoflavonoids, polyphenols, and bioflavonoids) on OA, and examines the known molecular effect and the possibility of their use for chondroprotection. MDPI 2021-04-20 /pmc/articles/PMC8074261/ /pubmed/33924083 http://dx.doi.org/10.3390/molecules26082391 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Sukhikh, Stanislav Noskova, Svetlana Ivanova, Svetlana Ulrikh, Elena Izgaryshev, Alexsander Babich, Olga Chondroprotection and Molecular Mechanism of Action of Phytonutraceuticals on Osteoarthritis |
title | Chondroprotection and Molecular Mechanism of Action of Phytonutraceuticals on Osteoarthritis |
title_full | Chondroprotection and Molecular Mechanism of Action of Phytonutraceuticals on Osteoarthritis |
title_fullStr | Chondroprotection and Molecular Mechanism of Action of Phytonutraceuticals on Osteoarthritis |
title_full_unstemmed | Chondroprotection and Molecular Mechanism of Action of Phytonutraceuticals on Osteoarthritis |
title_short | Chondroprotection and Molecular Mechanism of Action of Phytonutraceuticals on Osteoarthritis |
title_sort | chondroprotection and molecular mechanism of action of phytonutraceuticals on osteoarthritis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074261/ https://www.ncbi.nlm.nih.gov/pubmed/33924083 http://dx.doi.org/10.3390/molecules26082391 |
work_keys_str_mv | AT sukhikhstanislav chondroprotectionandmolecularmechanismofactionofphytonutraceuticalsonosteoarthritis AT noskovasvetlana chondroprotectionandmolecularmechanismofactionofphytonutraceuticalsonosteoarthritis AT ivanovasvetlana chondroprotectionandmolecularmechanismofactionofphytonutraceuticalsonosteoarthritis AT ulrikhelena chondroprotectionandmolecularmechanismofactionofphytonutraceuticalsonosteoarthritis AT izgaryshevalexsander chondroprotectionandmolecularmechanismofactionofphytonutraceuticalsonosteoarthritis AT babicholga chondroprotectionandmolecularmechanismofactionofphytonutraceuticalsonosteoarthritis |